- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12. | Neola Medical AB: Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market | 73 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a U.S. patent protecting its disposable probes for the medical device Neola®. The advanced light and detector probes are used... ► Artikel lesen | |
| 13.11. | Neola Medical AB: Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements | 99 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed... ► Artikel lesen | |
| 04.11. | Neola Medical AB Q3 Sales Increase | 4 | RTTNews | ||
| 04.11. | Neola Medical AB: Neola Medical Q3 Report 2025 - Progressing toward completion of Swedish clinical pilot study and strengthening leadership team | 33 | GlobeNewswire (Europe) | During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company's IP portfolio was reinforced in Europe with a newly granted patent... ► Artikel lesen | |
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.11. | Neola Medical AB: Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola | 49 | GlobeNewswire (Europe) | Preliminary results from Neola Medical's ongoing clinical pilot study on preterm born babies indicate a robust safety profile of the medical device Neola®.
The preliminary findings indicate variations... ► Artikel lesen | |
| 16.10. | Neola Medical AB: Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola | 109 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted patents in both the U.S. and China for a technical method that improve the accuracy of continuous lung monitoring with the company's medical device, Neola®.... ► Artikel lesen | |
| 25.09. | Neola Medical AB: Neola Medical strengthens leadership team with appointment of Clinical Director | 116 | GlobeNewswire (Europe) | Neola Medical AB (publ) is pleased to announce the appointment of Eva Bondesson as Clinical Director, effective October 1, 2025. As Neola Medical advances through the clinical phase, Eva Bondesson brings... ► Artikel lesen | |
| 10.09. | Neola Medical AB: Neola Medical granted European patent enabling lung monitoring beyond preterm born babies | 92 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a European patent for an invention aiming to enable lung monitoring in broader patient groups. This new patent complements the... ► Artikel lesen | |
| 25.08. | Neola Medical AB: Neola Medical Q2 Report 2025 - First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization | 109 | GlobeNewswire (Europe) | Neola Medical advanced its U.S. regulatory pathway in the second quarter of 2025, signing an agreement with Children's Regional Hospital at Cooper and securing IRB approval to enable the initiation... ► Artikel lesen | |
| 21.05. | Neola Medical AB: Neola Medical Q1 Report 2025 - Strengthened shareholder base with institutional investors ahead of clinical study start | 202 | GlobeNewswire (Europe) | The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately... ► Artikel lesen | |
| 25.03. | Neola Medical AB: Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies | 126 | GlobeNewswire (Europe) | Neola Medical is pleased to announce the signing of a contract with Södra Älvsborgs Sjukhus in Borås, to conduct the company's first clinical pilot study on preterm born babies, with its continuous... ► Artikel lesen | |
| 05.03. | Neola Medical AB: Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring | 198 | GlobeNewswire (Europe) | Neola Medical AB has been granted a patent in China that strengthens the protection of the company's fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous... ► Artikel lesen | |
| 12.02. | Neola Medical AB: Neola Medical Q4 Report 2024 - Received approval for initiation of first clinical pilot study on preterm born babies | 199 | GlobeNewswire (Europe) | Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,030 | +0,94 % | Starke Kursanstiege - AJN Resources, Delivery Hero, Siemens Healthineers | Ein massiver Stellenabbau betrifft nicht nur die deutsche Wirtschaft, auch in der Schweiz sind Umstrukturierungen erforderlich, um sich den Marktgegebenheiten anzupassen. Nach der überstürzten Übernahme... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,130 | +0,53 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,560 | -0,73 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,360 | -0,31 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,580 | +1,45 % | EQS-Adhoc: Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme des Vorstandsvorsitzes durch Andreas Pecher zum 01.01.2026 | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Personalie
Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 35,990 | -0,11 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| GERRESHEIMER | 28,040 | +6,62 % | Gerresheimer: Rückblick auf eine Trading-Idee! | ||
| BETA BIONICS | 29,760 | +1,54 % | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | ||
| GENEDX | 151,32 | -2,61 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| BRIGHTSPRING HEALTH SERVICES | 36,540 | +1,78 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| CASTLE BIOSCIENCES | 38,630 | +1,68 % | Castle Biosciences, Inc.: Systematic Review and Meta-Analysis Confirms TissueCypher Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer | FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication... ► Artikel lesen | |
| PROGYNY | 26,720 | +2,73 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HEARTBEAM | 2,300 | +7,98 % | Heartbeam stock is a buy, this analyst says | ||
| LUMEXA IMAGING | 18,530 | +0,05 % | Lumexa Imaging Announces Pricing of Initial Public Offering | RALEIGH, N.C., Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000... ► Artikel lesen | |
| ADAPTHEALTH | 10,400 | +1,46 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber |
Das Unternehmen NEOLA MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEOLA MEDICAL AB finden Sie auf Wallstreet Online.